Summary
Diabetes was induced in rats with equal molar dosages of either streptozotocin or alloxan. The clinical course of the diabetes (mortality, hyperglycemia, weight loss, polydipsia, hyperphagia, polyuria, glycosuria and diabetic indices) was recorded for six weeks before the animals were sacrificed for volumetric quantitation of the pancreatic islets. No significant differences in the pancreas (islet volumes of pancreas; beta, alpha and non-granular cell volumes and vessel volumes of both islet and total pancreas) were seen between the two groups, although differences in the clinical parameters were observed. The diabetic index at three and four weeks post injection was the clinical parameter which best reflected the terminal pancreatic beta cell volume. Analysis of the scanning data adds further empirical support for the accuracy of the linear scan method of quantitation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alrison, R.N., Ciaccio, E.I., Glitzer, M.S., Cassaro, J.A., Pruss, M.P.: Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes16, 51–56 (1967).
Brosky, G., Logothetopoulos, J.: Streptozotocin diabetes in the mouse and guinea pig. Diabetes18, 606–611 (1969).
Chang, A.Y., Schneider, D.I.: Hepatic enzyme activities in streptozotocin-diabetic rats before and after insulin treatment. Diabetes20, 71–77 (1971).
Dulin, W.E., Lund, G.H., Gerritsen, G.C.: Streptozotocin-induced diabetes in the rat. Diabetes16, 512–513 (1967).
Evans, J.S., Gerritsen, G.C., Mann, K.M., Owen, S.P.: Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its cofactor, U-15, 774. Cancer Chemother. Rep.48, 1–6 (1965).
Hoftiezer, V., Carpenter, A-M., Heggestad, C.B.: Early histologic changes in pancreatic islets after streptozotocin administration. Anat. Rec.166, 319 (1970).
Hoftiezer, V., Carpenter, A.-M., Heggestad, C.B.: Comparison of streptozotocin- and alloxan-induced diabetes in the rat. Anat. Rec.169, 341 (1971).
Junod, A., Lambert, A.E., Orci, L., Pictet, R., Gonet, A.E., Renold, A.E.: Studies of the diabetogenic action of streptozotocin. Proc. Soc. exp. Biol. Med.126, 201–205 (1967).
Junod, A., Lambert, A. E., Stauffacher, W., Renold, A.E.: Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J. clin. Invest.48, 2129–2139 (1969).
Lorch, E.: Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat. Diabetologia7, 195–203 (1971).
Mansford, K.R.L., Opie, L.: Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet1968 I, 670–671.
Petersson, B., Hellerstrom, C., Gunnarsson, R.: Structure and metabolism of the pancreatic islets in streptozotocin treated guinea pigs. Horm. Metab. Res.2, 313–317 (1970).
Pitkin, R.M., Reynolds, W.A.: Diabetogenic effects of streptozotocin in Rhesus monkeys. Diabetes19, 85–90 (1970).
Rakieten, N., Rakieten, M.L., Nadkarni, M.V.: Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep.29, 91–98 (1963).
Rerup, C.C.: Drugs producing diabetes through damage of insulin secreting cells. Pharmacol. Rev.22, 485–518 (1970).
Rerup, C.C., Tarding, F.: Comparison of the experimental diabetes induced by alloxan and streptozotocin in mice. Diabetologia4, 313 (1968).
Rerup, C.C., Tarding, F.: Streptozotocinandallox- and iabetes in mice. Europ. J. Pharmac.7, 89–96 (1969).
Schein, P.S., Bates, R.W.: Plasma glucose levels in normal and adrenalectomized mice treated with streptozotocin and nicotinamide. Diabetes17, 760–765 (1968).
Schein, P.S., Alberti, K.G.M.M., Williamson, D.H.: Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology89, 827–834 (1971).
Schlichtkrull, J.: Recent observations on pro-insulin and on streptozotocin diabetes. Diabetologia4, 18–19 (1968).
Stauffacher, W., Burr, I., Gutzeit, A., Deaven, D., Veleminsky, J., Renold, A.E.: Streptozotocin diabetes: time course of irreversible B-cell damage, further observations on prevention by nicotinamide. Proc. Soc. exp. Biol. Med.133, 194–200 (1970).
Steiner, H., Oelz, O., Zahnd, G., Froesch, E.R.: Studies on islet cell regeneration, hyperplasia and intrainsular cellular interrelations in long lasting streptozotocin diabetes in rats. Diabetologia6, 558–564 (1970).
Veleminsky, J., Burr, I.M., Stauffacher, W.: Comparative study of early metabolic events resulting from the administration of the two diabetogenic agents alloxan and streptozotocin. Europ. J. clin. Invest.1, 104–108 (1970).
Schein, P.S., Cooney, D.A., Vernon, M.L.: The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. Cancer Res.27, 2324–2332 (1967).
Logothetopoulos, J., Brosky, G.: Mitotic activity of islet cells in alloxan and streptozotocin diabetic mice studied by radioautography. Diabetes17, 306 (1968).
Hoffman, W. S.: A rapid photoelectric method for the determination of glucose in blood and urine. J. biol. Chem.120, 51–55 (1937).
Somogyi, M.: A rapid method for the estimation of urine sugar. J. Lab. clin. Med.26, 1220–1223 (1941).
Coupland, R.E., Davidson, J., Lazarow, A.: A diabetic index in the rat as determined by glucose tolerance tests. Anat. Rec.124, 394 (1956).
Gomori, G.: Aldehyde-fuchsin: a new stain for elastic tissue. Amer. J. clin. Path.20, 665–666 (1950).
Carpenter, A-M., Lazarow, A.: Component quantitation of tissue sections. II. A study of the factors which influence the accuracy of the method. J. Histochem. Cytochem.10, 329–340 (1962).
Lazarow, A., Carpenter, A-M.: Component quantitation of tissue sections. I. Characterization of the instruments. J. Histochem. Cytochem.10, 324 -328 (1962).
Carpenter, A-M., Lazarow, A.: Effects of hyper and hypoglycemia on beta cell degranulation and glycogen infiltration in normal, subdiabetic and diabetic rats. Diabetes16, 493–501 (1967).
Wright, D.L.: Quantitative studies of pancreatic islet components under various experimental conditions. Doctoral Dissertation. University of Minnesota (1968).
Lazarow, A., Carpenter, A-M., Morgan, C., Wright, D.: Effects of long-term administration of tolbutamide in normal, subdiabetic and diabetic rats. Diabetes11, 103–114 (1962).
Bunnag, S.C.: Postnatal neogenesis of islets of Langer hans in the mouse. Diabetes15, 480–491 (1966).
Hellman, B.: The numerical distribution of the islets of Langerhans at different ages of the rat. Acta endocr.32, 63–77 (1959).
Hellman, B.: The effect of aging on the number of the islets of Langerhans in the rats. Acta endocr.32, 78–91 (1959).
Haist, R.E.: Factors affecting the islets of Langer hans. Diabetes2, 295–298 (1953).
Haist, R.E., Pugh, E.J.: Volume measurement of the islet of Langerhans and the effects of age and fasting. Amer. J. Physiol.152, 36–41 (1948).
Hellman, B.: The total volume of the pancreatic islet tissue at different ages of the rat. Acta path, microbiol. scand.47, 35–50 (1959).
Hellman, B.: The volumetric distribution of the pancreatic islet tissue in young and old rats. Acta endocr.31, 91–106 (1959).
Petersson, B., Hellerstrom, C., Hellman, B.: The influence of the litter size on the postnatal growth of the islets of Langerhans in the rat. Acta. endocr.35, 533–540 (1960).
Hellman, B.: The relation between age and the B/A cell ratio in the islet tissue of the rat. Acta endocr.31, 80–90 (1959).
Carpenter, A-M., Gerritsen, G.C., Dulin, W.E., Lazarow, A.: Islet and beta cell volumes in diabetic Chinese hamsters and their non-diabetic siblings. Diabetologia3, 92–96 (1967).
Wright, D.L., Carpenter, A-M.: B-cell volumes in normal and sub-diabetic rats. Anat. Rec.139, 287–288 (1961).
Beloff-Chain, A., Rookledge, K.A.: The metabolism of glucose in diaphragm muscle from normal rats, from streptozotocin-treated diabetic rats and from rats treated with anti-insulin serum. Biochem. J.110, 529–532 (1968).
Duff, G.L., McMillan, G.C., Wilson, D.C.: Hydropic changes in pancreatic ductules and islets in alloxan diabetes in the rabbit. Proc. Soc. exp. Biol. Med.64, 251–255 (1947).
Goldner, M.G.: Alloxan diabetes, its production and mechanism. Bull. N.Y. Acad. Med.21, 44–55 (1945).
Kennedy, W.B., Lukens, F.D.W.: Observations on alloxan diabetes. Proc. Soc. exp. Biol. Med.57, 143–149 (1944).
Kvistberg, D.R., Lester, G., Lazarow, A.: Staining of insulin with aldehyde fuchsin. J. Histochem. Cytochem.14, 609–611 (1966).
Schein, P.S., Loftus, S.: Streptozotocin: depression of mouse liver pyridine nucleotides. Cancer Res.28, 1501–1506 (1968).
Author information
Authors and Affiliations
Additional information
Supported by USPHS Training Grant No. GM 114.
Rights and permissions
About this article
Cite this article
Hoftiezer, V., Carpenter, A.M. Comparison of streptozotocin and alloxan-induced diabetes in the rat, including volumetric quantitation of the pancreatic islets. Diabetologia 9, 178–184 (1973). https://doi.org/10.1007/BF01219780
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01219780